The Protein Tyrosine Phosphatase Nonreceptor 22 () R620W Functional Polymorphism in Psoriasis

Overview

Journal Clin Med Insights Arthritis Musculoskelet Disord

Publisher Sage Publications

Specialty Rheumatology

Date 2018 Jan 20

PMID 29348710

Citations 5

Authors

Ghaleb Bin Huraib

Fahad Al Harthi

Misbahul Arfin

Sadaf Rizvi

Abdulrahaman Al-Asmari

Affiliations

Soon will be listed here.

Abstract

Background: Psoriasis is a complex autoimmune disease caused by the interaction of genetic and environmental factors. gene polymorphism has been reported to affect psoriasis susceptibility; however, no data are available for Middle Eastern populations.

Objective: The aim of this study was to investigate the association of PTPN22 (1858C/T) R620W polymorphism with psoriasis in a Saudi cohort.

Methods: Saudi subjects (n = 306) including patients with psoriasis (n = 106) and matched controls (n = 200) were studied for variants using tetra-primer amplification refractory mutation system-polymerase chain reaction method. The frequencies of alleles and genotypes of PTPN22 (1858C/T) polymorphism were compared between patients and controls.

Results: The frequency of CT genotype of PTPN22 (1858C/T) polymorphism was significantly higher, whereas that of CC genotype was lower in patients with psoriasis than in controls (< .001, relative risk [RR] = 7.151). The homozygous genotype TT was absent in both the patients and healthy controls. The frequency of allele T encoding tryptophan (W) was significantly increased (< .001, RR = 5.76), whereas that of allele C encoding arginine (R) decreased in psoriasis cases as compared with controls (< .001, RR = 0.173) indicating that individuals carrying allele T are more susceptible to psoriasis than noncarriers.

Conclusions: PTPN22 (1858C/T) polymorphism is positively associated with susceptibility of psoriasis in Saudis and can be developed as biomarker for evaluating psoriasis risk. However, further studies on PTPN22 polymorphism in larger samples from different geographical areas and ethnicity are warranted.

Citing Articles

Psoriasis: An Immunogenetic Perspective.

Kocaaga A, Kocaaga M Glob Med Genet. 2022; 9(2):82-89.

PMID: 35707771 PMC: 9192173. DOI: 10.1055/s-0042-1743259.

Genetics, Epigenetics, Cellular Immunology, and Gut Microbiota: Emerging Links With Graves' Disease.

Zhou F, Wang X, Wang L, Sun X, Tan G, Wei W Front Cell Dev Biol. 2022; 9:794912.

PMID: 35059400 PMC: 8765724. DOI: 10.3389/fcell.2021.794912.

Evaluation of NLRP3 (rs10754558) and PTPN22 (1858C/T) (rs2476601) Functional Polymorphisms in Psoriasis Susceptibility in Egypt.

ALrefai A, Dawood A, Shehata W, Elhelbawy M, Elhelbawy N Appl Clin Genet. 2021; 14:331-339.

PMID: 34345180 PMC: 8324977. DOI: 10.2147/TACG.S319065.

Association of Functional Polymorphism in Protein Tyrosine Phosphatase Nonreceptor 22 (PTPN22) Gene with Vitiligo.

Huraib G, Al Harthi F, Arfin M, Aljamal A, Alrawi A, Al-Asmari A Biomark Insights. 2020; 15:1177271920903038.

PMID: 32076368 PMC: 7003175. DOI: 10.1177/1177271920903038.

Cannabinoid Signaling in the Skin: Therapeutic Potential of the "C(ut)annabinoid" System.

Toth K, Adam D, Biro T, Olah A Molecules. 2019; 24(5).

PMID: 30845666 PMC: 6429381. DOI: 10.3390/molecules24050918.

References

Sugiyama H, Gyulai R, Toichi E, Garaczi E, Shimada S, Stevens S . Dysfunctional blood and target tissue CD4+CD25high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation. J Immunol. 2004; 174(1):164-73. PMC: 2903964. DOI: 10.4049/jimmunol.174.1.164. View

Li Y, Chang M, Schrodi S, Callis-Duffin K, Matsunami N, Civello D . The 5q31 variants associated with psoriasis and Crohn's disease are distinct. Hum Mol Genet. 2008; 17(19):2978-85. PMC: 2536504. DOI: 10.1093/hmg/ddn196. View

Begovich A, Carlton V, Honigberg L, Schrodi S, Chokkalingam A, Alexander H . A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet. 2004; 75(2):330-7. PMC: 1216068. DOI: 10.1086/422827. View

Huffmeier U, Steffens M, Burkhardt H, Lascorz J, Schurmeier-Horst F, Stander M . Evidence for susceptibility determinant(s) to psoriasis vulgaris in or near PTPN22 in German patients. J Med Genet. 2005; 43(6):517-22. PMC: 2593025. DOI: 10.1136/jmg.2005.037515. View

Arechiga A, Habib T, He Y, Zhang X, Zhang Z, Funk A . Cutting edge: the PTPN22 allelic variant associated with autoimmunity impairs B cell signaling. J Immunol. 2009; 182(6):3343-7. PMC: 2797545. DOI: 10.4049/jimmunol.0713370. View

Scarpa R, Altomare G, Marchesoni A, Balato N, Cerinic M, Lotti T . Psoriatic disease: concepts and implications. J Eur Acad Dermatol Venereol. 2010; 24(6):627-30. DOI: 10.1111/j.1468-3083.2010.03574.x. View

Tang L, Wang Y, Zheng S, Bao M, Zhang Q, Li J . PTPN22 polymorphisms, but not R620W, were associated with the genetic susceptibility of systemic lupus erythematosus and rheumatoid arthritis in a Chinese Han population. Hum Immunol. 2016; 77(8):692-698. DOI: 10.1016/j.humimm.2016.04.021. View

Juneblad K, Johansson M, Rantapaa-Dahlqvist S, Alenius G . Association between the PTPN22 +1858 C/T polymorphism and psoriatic arthritis. Arthritis Res Ther. 2011; 13(2):R45. PMC: 3132030. DOI: 10.1186/ar3284. View

Icen M, Crowson C, McEvoy M, Dann F, Gabriel S, Kremers H . Trends in incidence of adult-onset psoriasis over three decades: a population-based study. J Am Acad Dermatol. 2009; 60(3):394-401. PMC: 3028518. DOI: 10.1016/j.jaad.2008.10.062. View

10.

Kouhpayeh H, Hashemi M, Hashemi S, Moazeni-Roodi A, Naderi M, Sharifi-Mood B . R620W functional polymorphism of protein tyrosine phosphatase non-receptor type 22 is not associated with pulmonary tuberculosis in Zahedan, southeast Iran. Genet Mol Res. 2012; 11(2):1075-81. DOI: 10.4238/2012.April.27.6. View

11.

Lee Y, Rho Y, Choi S, Ji J, Song G, Nath S . The PTPN22 C1858T functional polymorphism and autoimmune diseases--a meta-analysis. Rheumatology (Oxford). 2006; 46(1):49-56. DOI: 10.1093/rheumatology/kel170. View

12.

Criswell L, Pfeiffer K, Lum R, Gonzales B, Novitzke J, Kern M . Analysis of families in the multiple autoimmune disease genetics consortium (MADGC) collection: the PTPN22 620W allele associates with multiple autoimmune phenotypes. Am J Hum Genet. 2005; 76(4):561-71. PMC: 1199294. DOI: 10.1086/429096. View

13.

Chen Y, Chang J . PTPN22 C1858T and the risk of psoriasis: a meta-analysis. Mol Biol Rep. 2012; 39(8):7861-70. DOI: 10.1007/s11033-012-1630-z. View

14.

Zhang Z, Chen F, Zhang X, Jin Y, Bai J, Fu S . PTPN22 allele polymorphisms in 15 Chinese populations. Int J Immunogenet. 2008; 35(6):433-7. DOI: 10.1111/j.1744-313X.2008.00803.x. View

15.

Ishida-Yamamoto A, Senshu T, Takahashi H, Akiyama K, Nomura K, Iizuka H . Decreased deiminated keratin K1 in psoriatic hyperproliferative epidermis. J Invest Dermatol. 2000; 114(4):701-5. DOI: 10.1046/j.1523-1747.2000.00936.x. View

16.

Nistor I, Nair R, Stuart P, Hiremagalore R, Thompson R, Jenisch S . Protein tyrosine phosphatase gene PTPN22 polymorphism in psoriasis: lack of evidence for association. J Invest Dermatol. 2005; 125(2):395-6. DOI: 10.1111/j.0022-202X.2005.23802.x. View

17.

Dogra S, Yadav S . Psoriasis in India: prevalence and pattern. Indian J Dermatol Venereol Leprol. 2010; 76(6):595-601. DOI: 10.4103/0378-6323.72443. View

18.

Choon S, Lai N, Mohammad N, Nanu N, Tey K, Chew S . Clinical profile, morbidity, and outcome of adult-onset generalized pustular psoriasis: analysis of 102 cases seen in a tertiary hospital in Johor, Malaysia. Int J Dermatol. 2013; 53(6):676-84. DOI: 10.1111/ijd.12070. View

19.

Zhang Z, Yuan J, Tian Z, Xu J, Lu Z . Investigation of 36 non-HLA (human leucocyte antigen) psoriasis susceptibility loci in a psoriatic arthritis cohort. Arch Dermatol Res. 2016; 309(2):71-77. DOI: 10.1007/s00403-016-1706-z. View

20.

Schmitt J, Wozel G . The psoriasis area and severity index is the adequate criterion to define severity in chronic plaque-type psoriasis. Dermatology. 2005; 210(3):194-9. DOI: 10.1159/000083509. View